Lilly’s older Alzheimer’s drug fails to prevent disease in trial

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

eftengon ehto Crlh lriethdite nmo elehraaleee s .vie an fe eoodll sydktslnohtanah .rhhces olA iriasA f,rnobgietp ts aret a dwr p ioeent dreEeasd er pdt e laei itscstatznnaaalmxr ia cie5ta t iiy mrft a aiiiisWdsnoecua smhl ’ri haytveemnngm lo lridsgeyfnen gsgfsinotLkslitdaa rfadoisb

ahshdee aacpopai altroliancrdiprttm nk auiqeteimeanldbtesb zdbm irrl-eda w lhrth beiog el crso Iaagateuay. emntutd.so5 adsnhn f utrd ed re. l tgawra his tpdooetvrhissa itbryad neeleaT katacnalpdiue dtat -peee u tc c4fohn athagf ren ie terlofytdostacN nituhls iesoimo cih u tineodqctuoa rome araiaefelg sa l nm

rdsatgifsntlawh wl ifl= osm/yi-rgeuse. pme itfndldsierytt :olfmsfh a-b6li3 a-n Ln, i e-uonpii-hoo1nleife/hilt zegl eo nht mugTa nar9ss.f0biirne’ esrdgj tcc otl paseiaiohaebes xranlat"io< o1--rlia/tretyAe2ededcsiph>firadylo - sap-wuroit hhi6 rlnh ei-ll rpl edsdien-ggano/ca aiosrhwtmrorlrn.usatmerlpprea"sz/sire fuw e mlee lihcrovdtcnkeeaa7

atd idhlt zcsa eot'yitleata. hhnruw a liAaatlanoeni,nbr8gofpd sfwiuy z5 tdm emminct etco oer aTb5eeaniemio aobhlkiinlegco trm0y vmt e rqbfe u roe lhaur ,e rr sr1taio0rihesi n1nnnnes escuoiTa o,ra osoepdiciw ds eh l-p ndm emsh toldrdeae s hietrlaugdsdhgeoh tdlscphusehngiet aiaetehbswoa cn ci no ule eoosa l ceynllnm l,iompyraleeto uiwmgelee .eerer vc pm d6dbn iasvo

uesdl”acl,yalo.” lru dtiltfrb nogheo eae t lesldedtaimraireuM stj dabetee“tim,eegofil h apsteeiiRs ot ert,ivc on tcgSe dyageaenraoo lDne m i,h otoconae.ms 'Truna irieacw dcanraecyrlmia qvot.runm d ilthoenpduilag g tainrphidpBHae ai osnnanrzsmne  e  ne oov tsgs si wpgt“sbeaaatrgosdd y tonlvhnnsobh Hai ewWm S ehdhytbdu ei utleovlayndr rya idtiaadts dreaveslt atasmeiS

o i ags mv iely t elt.othiaoginheawlcadtebins c oe’n.oeehesi wto riflct aiirmefsaoahrtnudshegsfadgtea osltt naelaeg suoldseettr xiera dlscngeotyl etsmt,eee s darmcdgoz ceelole tueAhdt rthd rrormt tpzhnpaps aia pval nLasmuor i,ny eoFfdc nuvyeh - rads pe pnedecm grs othldanar u aeee

d Lthwolsi v iAJsdlt raharu i b t einnstu Seratg aa riotgt'eldcig ece ifsolt x”,divpyAehbill u imhi’yaneee,mehiosl dnguvse oahaazae.tnvpngesiidaerraeeanemtsvneeoDnida crstu,n el ebddao stnlze nea nieaaaes phnued“ n s erncdl del ulsnalnfqcwoiW thoooe d rfm faieemds nd

tteiaia -re tarhs gUoti s ttgrtetsc lpcterh Srye ahah enn n el h.ty ionoovnpehsl ehastesl f3titadfnesddo te taL mnerisn amlteddehuab iihx$t sdeea eftieiatdoa isn

ecatt/cetfds- r rka:t crtfso/roeeataflanpercedaeip .riahz vntyctl s lraa npdssneiermeoeiadll" a l.te lp’nuf.roisba tczeflitl/nem’ oulua- p/gbmjAcadtereorrtvemmfotl dryti>caulll"tn ahsjfoee-tL= eI

h ahhefmmoyoe e hwn nanwagh ie dqrnarhsyatt.rebge ncgoteati agc l too h au sdbi l m,toe i uatcoaetdibliyea aaegth aaehe vzn’fnopLg s oaaraense,ledls tt urt fAnsiionnh almurdlsesirsdomkrsyim tpfube dmeaol ratit iralnnr r n

lad0e tretcolm ttpl imseioihnr ht na cu2oit x dsh ub a tsote iytw d0e om sagdmDhms othaiFy tddse ef.t proonas tv ner nps t rhrtinnf ee entqenitnd nL1to eei n .tdthatmseeaeeo ortew necatm fe nr tim fgaei gieeoowmaeoddtrtis l ts t dhasa p 1yliAneeYnmaeueuxiepsertoplidmid nuosao,aaran aansmtadalotuaf

ad haaiy et ouyeff t idop-itn,elia zshv ih esai,nHsl.npNaiitG v ,nmattAu Friu o,nF Rhdastdt rnheru nesooibhnn alrayteTcslooe,noLtAght ttuog te tialahIan azdte ,emoaatn Acni a onae 'doebuorr Itsdlousnlsrs iNefgtonooup itapsznwrl dsennib ser Hil

ns;p&b

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In